Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - Shire plc | dp41238_8k.htm |
Exhibit 99.01
|
Press Release
|
 |
|
www.shire.com
|
Dublin, Ireland – October 10, 2013 – Shire plc (LSE: SHP, NASDAQ: SHPG), will announce third quarter 2013 earnings on Thursday October 24, 2013.
|
Results press release will be issued at:
|
12:00 BST / 07:00 EDT
|
|
Investor conference call time:
|
14:00 BST / 09:00 EDT
|
Live conference call for investors:
Flemming Ornskov, MD, Chief Executive Officer and Graham Hetherington, Chief Financial Officer will host the investor and analyst conference call at 14:00 BST/9:00 EDT.
The details of the conference call are as follows:
|
UK dial in:
|
08082370030 or 02031394830
|
|
US dial in:
|
1 866 928 7517 or 1 718 873 9077
|
|
International Access Numbers:
|
http://wpc.1726.planetstream.net/001726/FEL_Events_International_Access_List.pdf
|
|
Password/Conf ID:
|
71566006#
|
|
Live Webcast:
|
http://www.shire.com/shireplc/en/investors
|
Replay:
A replay of the presentation will be available for two weeks by phone and by webcast for three months. Details can be found on our Investor Relations website http://www.shire.com/shireplc/en/investors.
For further information please contact:
|
Investor Relations
|
Souheil Salah (ssalah@shire.com)
|
+44 1256 894 160
|
NOTES TO EDITORS
Shire enables people with life-altering conditions to lead better lives.
Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.
We provide treatments in Neuroscience, Rare Diseases, Gastrointestinal, Internal Medicine and Regenerative Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas.
www.shire.com
Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX